Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Scientists discover how rare amino acid influences E.coli
Minced beef
Eating contaminated food is the most common cause of the E.coli 0157 infection.
Work provides new insights into the infection process

Research by the University of Glasgow has revealed how a rare amino-acid in humans influences the behaviour of the bacteria, E.coli.

The finding opens up the possibility of altering the diet to increase levels of D-Serine, an amino acid produced in the brain, to prevent, or even treat, infection caused by the strain E.coli 0157.

E.coli 0157 is one of the most well-known strains of E.Coli which can cause illness. It is typically acquired via contaminated food and can cause severe diarrhea and kidney damage.

The 0157 strain only infects the gut, so scientists at the University of Glasgow wanted to know what stopped it from spreading to other parts of the body.

Led by Dr Andrew Roe and PhD student James Connolly of the Institute of Infection, Immunity & Inflammation, the team analysed the genome sequence of 1,500 strains of E.coli. Their aim was to discover how genes of the bug, which enable it to attach to and infect a host, responded to varying concentrations of D-serine, an amino-acid produced in the brain where it plays a role in nerve signalling.

They found that E.coli 0157 is unable to attach itself to host tissue in high concentrations of D-Serine. Other strains, such as those that cause meningitis, thrive in the present of amino aside.

Dr Andrew Roe, senior lecturer, said: “This work provides new insights into the infection process with the aim of developing compounds that block such bugs from attaching to the host.

“With many strains of E. coli developing resistance to traditional antibiotics, such approaches are urgently needed.

“If we can disarm such bacteria rather than killing them it puts less pressure on the bacteria to evolve into something that is resistant to treatment.”

The study was funded by the Medical Research Council and has been published in the ISME journal.

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.